Cargando…

Tuberculosis Biomarkers: From Diagnosis to Protection

New approaches to control tuberculosis (TB) worldwide are needed. In particular, new tools for diagnosis and new biomarkers are required to evaluate both pathogen and host key elements of the response to infection. Non-sputum based diagnostic tests, biomarkers predictive of adequate responsiveness t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goletti, Delia, Petruccioli, Elisa, Joosten, Simone A., Ottenhoff, Tom H.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927936/ https://www.ncbi.nlm.nih.gov/pubmed/27403267 http://dx.doi.org/10.4081/idr.2016.6568

Ejemplares similares

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
por: Petruccioli, Elisa, et al.
Publicado: (2016)

B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis
por: Rijnink, Willemijn F., et al.
Publicado: (2021)

Higher Frequency of T-Cell Response to M. tuberculosis Latency Antigen Rv2628 at the Site of Active Tuberculosis Disease than in Peripheral Blood
por: Chiacchio, Teresa, et al.
Publicado: (2011)

Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19
por: Pierneef, Louise, et al.
Publicado: (2022)

Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis
por: Delemarre, Eveline M., et al.
Publicado: (2021)

Biomarkers Can Identify Pulmonary Tuberculosis in HIV-infected Drug Users Months Prior to Clinical Diagnosis
por: Sloot, Rosa, et al.
Publicado: (2014)

Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis
por: de Waal, Amy M, et al.
Publicado: (2022)

Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment
por: Joosten, Simone A., et al.
Publicado: (2016)

Harnessing donor unrestricted T-cells for new vaccines against tuberculosis
por: Joosten, Simone A., et al.
Publicado: (2019)

Antibody glycosylation in inflammation, disease and vaccination
por: Alter, Galit, et al.
Publicado: (2018)

Optimization of the autophagy measurement in a human cell line and primary cells by flow cytometry
por: Alonzi, Tonino, et al.
Publicado: (2019)

Human CD4 T-Cells With a Naive Phenotype Produce Multiple Cytokines During Mycobacterium Tuberculosis Infection and Correlate With Active Disease
por: Orlando, Valentina, et al.
Publicado: (2018)

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q
por: Niewold, Paula, et al.
Publicado: (2023)

Patients with Concurrent Tuberculosis and Diabetes Have a Pro-Atherogenic Plasma Lipid Profile
por: Vrieling, Frank, et al.
Publicado: (2018)

Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection
por: Petruccioli, Elisa, et al.
Publicado: (2018)

Biomarkers to identify Mycobacterium tuberculosis infection among borderline QuantiFERON results
por: Uzorka, Jonathan W., et al.
Publicado: (2022)

Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
por: Lubbers, Rosalie, et al.
Publicado: (2018)

Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
por: Esmail, Hanif, et al.
Publicado: (2020)

Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosis
por: Dijkman, Karin, et al.
Publicado: (2020)

A Helicopter Perspective on TB Biomarkers: Pathway and Process Based Analysis of Gene Expression Data Provides New Insight into TB Pathogenesis
por: Joosten, Simone A., et al.
Publicado: (2013)

The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group
por: Melkie, Solomon Tibebu, et al.
Publicado: (2022)

Plasma metabolomics in tuberculosis patients with and without concurrent type 2 diabetes at diagnosis and during antibiotic treatment
por: Vrieling, Frank, et al.
Publicado: (2019)

MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8(+) T cells and contributes to protection against infection
por: Bian, Yao, et al.
Publicado: (2017)

The ubiquitin ligase TRIM32 promotes the autophagic response to Mycobacterium tuberculosis infection in macrophages
por: Romagnoli, Alessandra, et al.
Publicado: (2023)

In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses
por: Najafi Fard, Saeid, et al.
Publicado: (2021)

Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases
por: Joosten, Simone A., et al.
Publicado: (2016)

Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses
por: Geluk, Annemieke, et al.
Publicado: (2014)

Identification of Probable Early-Onset Biomarkers for Tuberculosis Disease Progression
por: Sutherland, Jayne S., et al.
Publicado: (2011)

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
por: Petruccioli, Elisa, et al.
Publicado: (2021)

The role of donor‐unrestricted T‐cells, innate lymphoid cells, and NK cells in anti‐mycobacterial immunity
por: Ruibal, Paula, et al.
Publicado: (2021)

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
por: Petrone, Linda, et al.
Publicado: (2021)

Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy
por: Romagnoli, Alessandra, et al.
Publicado: (2018)

Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
por: Grace, Patricia S., et al.
Publicado: (2021)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction
por: Vrieling, Frank, et al.
Publicado: (2019)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

The Effect of Hyperglycaemia on In Vitro Cytokine Production and Macrophage Infection with Mycobacterium tuberculosis
por: Lachmandas, Ekta, et al.
Publicado: (2015)

A Systematic Review on Novel Mycobacterium tuberculosis Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis
por: Meier, Noëmi R., et al.
Publicado: (2018)

Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis
por: Smith, Steven G., et al.
Publicado: (2009)

Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis
por: Camassa, Serena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3pcq321gsu5dc99lkpjnp4pk6h